{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:30:20Z","timestamp":1792121420056,"version":"4.4.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T00:00:00Z","timestamp":1347926400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1007\/s00262-012-1348-8","type":"journal-article","created":{"date-parts":[[2012,9,17]],"date-time":"2012-09-17T06:29:29Z","timestamp":1347863369000},"page":"481-487","source":"Crossref","is-referenced-by-count":43,"title":["Up-regulation of Foxp3 participates in progression of cervical cancer"],"prefix":"10.1007","volume":"62","author":[{"given":"Chao","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,18]]},"reference":[{"key":"1348_CR1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/j.vaccine.2006.05.111","volume":"24","author":"D Parkin","year":"2006","unstructured":"Parkin D, Bray F (2006) Chapter 2: The burden of HPV-related cancers. Vaccine 24:S11\u2013S25","journal-title":"Vaccine"},{"key":"1348_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cncr.22425","volume":"111","author":"D Dehn","year":"2007","unstructured":"Dehn D, Torkko KC, Shroyer KR (2007) Human Papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 111:1\u201314","journal-title":"Cancer"},{"key":"1348_CR3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/nri1488","volume":"4","author":"PJ Coffer","year":"2004","unstructured":"Coffer PJ, Burgering BM (2004) Forkhead-box transcription factors and their role in the immune system. Nat Rev Immunol 4:889\u2013899","journal-title":"Nat Rev Immunol"},{"key":"1348_CR4","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.immuni.2005.01.016","volume":"22","author":"JD Fontenot","year":"2005","unstructured":"Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22:329\u2013341","journal-title":"Immunity"},{"key":"1348_CR5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","volume":"299","author":"S Hori","year":"2003","unstructured":"Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299:1057\u20131061","journal-title":"Science"},{"key":"1348_CR6","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","volume":"169","author":"UK Liyanage","year":"2002","unstructured":"Liyanage UK, Moore TT, Joo HG, Tanaka Y, Herrmann V, Doherty G, Drebin JA, Strasberg SM, Eberlein TJ, Goedegebuure PS, Linehan DC (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169:2756\u20132761","journal-title":"J Immunol"},{"key":"1348_CR7","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1158\/1078-0432.CCR-06-0369","volume":"12","author":"N Hiraoka","year":"2006","unstructured":"Hiraoka N, Onozato K, Kosuge T, Hirohashi S (2006) Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res 12:5423\u20135434","journal-title":"Clin Cancer Res"},{"key":"1348_CR8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejso.2007.08.008","volume":"34","author":"A Sasaki","year":"2008","unstructured":"Sasaki A, Tanaka F, Mimori K, Inoue H, Kai S, Shibata K, Ohta M, Kitano S, Mori M (2008) Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma. Eur J Surg Oncol 34:173\u2013179","journal-title":"Eur J Surg Oncol"},{"key":"1348_CR9","doi-asserted-by":"crossref","first-page":"8344","DOI":"10.1158\/0008-5472.CAN-06-3304","volume":"67","author":"S Hinz","year":"2007","unstructured":"Hinz S, Pagerols-Raluy L, Oberg HH, Ammerpohl O, Gr\u00fcssel S, Sipos B, Gr\u00fctzmann R, Pilarsky C, Ungefroren H, Saeger HD, Kl\u00f6ppel G, Kabelitz D, Kalthoff H (2007) Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer. Cancer Res 67:8344\u20138350","journal-title":"Cancer Res"},{"key":"1348_CR10","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1200\/JCO.2008.17.9036","volume":"27","author":"A Merlo","year":"2009","unstructured":"Merlo A, Casalini P, Carcangiu ML, Malventano C, Triulzi T, M\u00e8nard S, Tagliabue E, Balsari A (2009) FOXP3 expression and overall survival in breast cancer. J Clin Oncol 27:1746\u20131752","journal-title":"J Clin Oncol"},{"key":"1348_CR11","first-page":"3765","volume":"117","author":"T Zuo","year":"2007","unstructured":"Zuo T, Liu R, Zhang H, Chang X, Liu Y, Wang L, Zheng P, Liu Y (2007) FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J Clin Invest 117:3765\u20133773","journal-title":"J Clin Invest"},{"key":"1348_CR12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ccr.2009.08.016","volume":"16","author":"L Wang","year":"2009","unstructured":"Wang L, Liu R, Li W, Chen C, Katoh H, Chen GY, McNally B, Lin L, Zhou P, Zuo T, Cooney KA, Liu Y, Zheng P (2009) Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate. Cancer Cell 16:336\u2013346","journal-title":"Cancer Cell"},{"key":"1348_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/ni1455","volume":"8","author":"Y Zheng","year":"2007","unstructured":"Zheng Y, Rudensky AY (2007) Foxp3 in control of the regulatory T cell lineage. Nat Immunol 8:457\u2013462","journal-title":"Nat Immunol"},{"key":"1348_CR14","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","volume":"6","author":"S Sakaguchi","year":"2005","unstructured":"Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345\u2013352","journal-title":"Nat Immunol"},{"key":"1348_CR15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.21.120601.141122","volume":"22","author":"S Sakaguchi","year":"2004","unstructured":"Sakaguchi S (2004) Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22:531\u2013562","journal-title":"Annu Rev Immunol"},{"key":"1348_CR16","first-page":"791","volume":"28","author":"HY Zhang","year":"2010","unstructured":"Zhang HY, Sun H (2010) Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer Lett 28:791\u2013797","journal-title":"Cancer Lett"},{"key":"1348_CR17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.6061\/clinics\/2012(05)13","volume":"67","author":"LL Cunha","year":"2012","unstructured":"Cunha LL, Morari EC, Nonogaki S, Soares FA, Vassallo J, Ward LS (2012) Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomas. Clinics 67:483\u2013488","journal-title":"Clinics"},{"key":"1348_CR18","first-page":"3545","volume":"123","author":"LH Wang","year":"2010","unstructured":"Wang LH, Lin S, Wang JT (2010) Correlation between elevated FOXP3 expression and increase lymph node metastasis of gastric cancer. Chin Med J 123:3545\u20133549","journal-title":"Chin Med J"},{"key":"1348_CR19","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00262-011-1025-3","volume":"60","author":"J Niu","year":"2011","unstructured":"Niu J, Jiang C, Li C, Liu L, Li K, Jian Z, Gao T (2011) Foxp3 expression in melanoma cells as a possible mechanism of resistance to immune destruction. Cancer Immunol Immunother 60:1109\u20131118","journal-title":"Cancer Immunol Immunother"},{"key":"1348_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.lungcan.2011.06.002","volume":"75","author":"H Tao","year":"2012","unstructured":"Tao H, Mimura Y, Aoe K, Kobayashi S, Yamamoto H, Matsuda E, Okabe K, Matsumoto T, Sugi K, Ueoka H (2012) Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells. Lung Cancer 75:95\u2013101","journal-title":"Lung Cancer"},{"key":"1348_CR21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/modpathol.2008.25","volume":"21","author":"K Karube","year":"2008","unstructured":"Karube K, Aoki R, Sugita Y, Yoshida S, Nomura Y, Shimizu K, Kimura Y, Hashikawa K, Takeshita M, Suzumiya J, Utsunomiya A, Kikuchi M, Ohshima K (2008) The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma. Mod Pathol 21:617\u2013625","journal-title":"Mod Pathol"},{"key":"1348_CR22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.vetimm.2009.05.014","volume":"132","author":"K Bolzer","year":"2009","unstructured":"Bolzer K, K\u00e4ser T, Saalm\u00fcller A, Hammer SE (2009) Molecular characterisation of porcine Forkhead-box p3 (Foxp3). Vet Immunol Immunopathol 132:275\u2013281","journal-title":"Vet Immunol Immunopathol"},{"key":"1348_CR23","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s004410050048","volume":"300","author":"E Boisvieux-Ulrich","year":"2000","unstructured":"Boisvieux-Ulrich E, Le Pechon-Vall\u00e9e C, Million K, Baeza-Squiban A, Houcine O, Guennou C, Reichert U, Marano F (2000) Differential effects of several retinoid receptor-selective ligands on squamous differentiation and apoptosis in airway epithelial cells. Cell Tissue Res 300:67\u201381","journal-title":"Cell Tissue Res"},{"key":"1348_CR24","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.3748\/wjg.v16.i43.5502","volume":"16","author":"WH Wang","year":"2010","unstructured":"Wang WH, Jiang CL, Yan W, Zhang YH, Yang JT, Zhang C, Yan B, Zhang W, Han W, Wang JZ, Zhang YQ (2010) FOXP3 expression and clinical characteristics of hepatocellular carcinoma. World J Gastroenterol 16:5502\u20135509","journal-title":"World J Gastroenterol"},{"key":"1348_CR25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/cncr.23951","volume":"114","author":"RA Halloush","year":"2008","unstructured":"Halloush RA, Akpolat I, Jim Zhai Q, Schwartz MR, Mody DR (2008) Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study. Cancer 114:474\u2013480","journal-title":"Cancer"},{"key":"1348_CR26","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00000478-200211000-00001","volume":"26","author":"R Klaes","year":"2002","unstructured":"Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, Kurman RJ, Schmidt D, Stoler M, von Knebel Doeberitz M (2002) p16 immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26:1389\u20131399","journal-title":"Am J Surg Pathol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1348-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-012-1348-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-012-1348-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:33:17Z","timestamp":1558715597000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-012-1348-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,18]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["1348"],"URL":"https:\/\/doi.org\/10.1007\/s00262-012-1348-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,18]]}}}